Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “New York”
- A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk MelanomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Acral Lentiginous Melanoma · Clinical Stage III Cutaneous Melanoma AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Mucosal Melanoma
United States
- Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic AgentsActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Fallopian Tube Mucinous Adenocarcinoma · Ovarian Seromucinous Carcinoma · Platinum-Refractory Fallopian Tube Carcinoma · Platinum-Refractory Ovarian Carcinoma
United States, Puerto Rico
Sponsor: National Cancer Institute (NCI)
Progressive Glioblastoma · Recurrent Glioblastoma
United States
- Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Fallopian Tube High Grade Serous Adenocarcinoma · Ovarian High Grade Serous Adenocarcinoma · Ovarian Seromucinous Carcinoma · Primary Peritoneal High Grade Serous Adenocarcinoma
United States, Puerto Rico
- Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Cervical Adenocarcinoma · Cervical Adenosquamous Carcinoma · Recurrent Cervical Carcinoma · Stage IV Cervical Cancer AJCC v6 and v7
United States
Sponsor: NRG Oncology
Stage III Colon Cancer
United States, Canada, Puerto Rico
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Functioning Pancreatic Neuroendocrine Tumor · Intermediate Grade Lung Neuroendocrine Neoplasm · Locally Advanced Digestive System Neuroendocrine Neoplasm · Locally Advanced Digestive System Neuroendocrine Tumor G1
United States
- Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Metastatic Bladder Urothelial Carcinoma · Metastatic Urothelial Carcinoma · Refractory Bladder Urothelial Carcinoma · Refractory Urothelial Carcinoma
United States
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.Active Not Recruiting
Sponsor: Boston Scientific Corporation
Heart Failure
United States
- Testing Immunotherapy Versus Observation in Patients With HPV Throat CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
United States
Sponsor: Boston Scientific Corporation
Heart Failure - NYHA II - IV
United States
- Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After SurgeryActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Anal Melanoma · Bladder Melanoma · Cervical Melanoma · Esophageal Melanoma
United States, Canada
- Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IIIC Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
United States, Canada, Guam
- Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 MelanomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Clinical Stage III Cutaneous Melanoma AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Metastatic Melanoma · Recurrent Melanoma
United States
- NCI COVID-19 in Cancer Patients, NCCAPS StudyActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
COVID-19 Infection · Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm
United States, Canada, Puerto Rico
- A Study of Barzolvolimab in Patients With Prurigo NodularisActive Not Recruiting
Sponsor: Celldex Therapeutics
Prurigo Nodularis
United States, Canada, Croatia, Germany, Poland +1 more
- Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Anemia · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States
- Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Anal Basaloid Carcinoma · Anal Canal Cloacogenic Carcinoma · Anal Margin Squamous Cell Carcinoma · Stage IIB Anal Cancer AJCC v8
United States, Canada
- Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)Active Not Recruiting
Sponsor: National Cancer Institute (NCI)
Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage II Lung Non-Small Cell Cancer AJCC v7 · Stage IIIA Lung Non-Small Cell Cancer AJCC v7
United States
Sponsor: EyePoint Pharmaceuticals, Inc.
Diabetic Macular Edema · DME · Diabetic Macular Edema (DME)
United States, Germany, Israel, Poland, Slovakia
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Autistic Disorder · Behavioral Symptoms
United States
- A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to VedolizumabActive Not Recruiting
Sponsor: AbbVie
Ulcerative Colitis
United States, Austria, Bulgaria, Canada, China +26 more
Sponsor: TerSera Therapeutics LLC
Advanced Breast Cancer
United States
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Neck Squamous Cell Carcinoma of Unknown Primary · Recurrent Hypopharyngeal Squamous Cell Carcinoma · Recurrent Laryngeal Squamous Cell Carcinoma · Recurrent Laryngeal Verrucous Carcinoma
United States, Puerto Rico, South Africa
Sponsor: NRG Oncology
Breast Cancer · Depression
United States, Puerto Rico